Published in J Neurosurg on November 27, 2009
Functional outcome and postoperative complications after the microsurgical removal of large vestibular schwannomas via the retrosigmoid approach: a meta-analysis. Neurosurg Rev (2013) 0.87
Factors associated with preservation of facial nerve function after surgical resection of vestibular schwannoma. J Neurooncol (2010) 0.86
Small Vestibular Schwannomas: Does Surgery Remain a Viable Treatment Option? J Neurol Surg B Skull Base (2015) 0.78
Large vestibular schwannomas. J Neurosurg (2011) 0.78
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. Transl Res (2015) 0.75
Long-term follow-up after stereotactic radiosurgery of intracanalicular acoustic neurinoma. Radiat Oncol (2017) 0.75
Morbidity in vestibular schwannoma surgery. J Neurosurg (2013) 0.75
Functional outcome and complications after the microsurgical removal of giant vestibular schwannomas via the retrosigmoid approach: a retrospective review of 16-year experience in a single hospital. BMC Neurol (2017) 0.75
An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg (2011) 6.32
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Sensitivity of noncontrast cranial computed tomography for the emergency department diagnosis of subarachnoid hemorrhage. Ann Emerg Med (2008) 3.76
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma. J Clin Oncol (2008) 2.71
Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg (2010) 2.42
Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg (2010) 2.19
Modern surgical outcomes following surgery for sphenoid wing meningiomas. J Neurosurg (2013) 2.16
Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2009) 2.15
Complications of lumboperitoneal shunts. Neurosurgery (2007) 2.07
Soluble factors secreted by glioblastoma cell lines facilitate recruitment, survival, and expansion of regulatory T cells: implications for immunotherapy. Neuro Oncol (2012) 2.04
Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res (2013) 1.86
Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg (2010) 1.74
Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas. World Neurosurg (2010) 1.72
Posttreatment prognosis of patients with esthesioneuroblastoma. J Neurosurg (2010) 1.67
The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. J Neurosurg (2010) 1.67
Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J Neurosurg (2011) 1.67
Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg (2008) 1.66
Cancer and the complement cascade. Mol Cancer Res (2010) 1.64
Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg (2012) 1.64
The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci (2009) 1.62
Treatment-related morbidity and the management of pediatric craniopharyngioma: a systematic review. J Neurosurg Pediatr (2012) 1.57
Intratumoral hemorrhage and fibrosis in vestibular schwannoma: a possible mechanism for hearing loss. J Neurosurg (2010) 1.55
Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011. J Neurosurg (2013) 1.55
Atypia predicting prognosis for intracranial extraventricular neurocytomas. J Neurosurg (2011) 1.54
Extent of resection and the long-term durability of vestibular schwannoma surgery. J Neurosurg (2011) 1.53
Risk factors for the development of serious medical complications after resection of meningiomas. Clinical article. J Neurosurg (2010) 1.53
Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res (2006) 1.52
Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review. J Neurosurg Spine (2013) 1.51
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg (2015) 1.48
Prevalence of previous extracranial malignancies in a series of 1228 patients presenting with meningioma. J Neurosurg (2010) 1.48
Gliomas: advances in molecular analysis and characterization. Surg Neurol (2005) 1.46
A prospective study of hearing preservation in untreated vestibular schwannomas. J Neurosurg (2010) 1.46
What clinical factors predict the incidence of deep venous thrombosis and pulmonary embolism in neurosurgical patients? J Neurosurg (2014) 1.44
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro Oncol (2009) 1.43
Reward-dependent plasticity in the primary auditory cortex of adult monkeys trained to discriminate temporally modulated signals. Proc Natl Acad Sci U S A (2003) 1.42
Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg (2010) 1.38
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol (2012) 1.38
Intracranial hemangiopericytoma: clinical experience and treatment considerations in a modern series of 40 adult patients. Cancer (2011) 1.35
Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function. J Immunother (2009) 1.33
The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus (2011) 1.33
Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. J Neurosurg (2009) 1.32
Predictors of mortality following treatment of intracranial hemangiopericytoma. J Neurosurg (2010) 1.28
Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging. Radiology (2010) 1.28
CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival. J Clin Neurosci (2010) 1.26
Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity. J Neurooncol (2009) 1.25
Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg (2005) 1.25
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial. Neuro Oncol (2013) 1.25
Changes in transcranial motor evoked potentials during intramedullary spinal cord tumor resection correlate with postoperative motor function. Neurosurgery (2005) 1.24
Representation of spectral and temporal envelope of twitter vocalizations in common marmoset primary auditory cortex. J Neurophysiol (2002) 1.16
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein. Clin Cancer Res (2012) 1.15
The complement cascade as a mediator of tissue growth and regeneration. Inflamm Res (2010) 1.14
Temozolomide and other potential agents for the treatment of glioblastoma multiforme. Neurosurg Clin N Am (2012) 1.13
Neurosurgical management and prognosis of patients with glioblastoma that progresses during bevacizumab treatment. Neurosurgery (2012) 1.13
A systematic review of intracranial chondrosarcoma and survival. J Clin Neurosci (2009) 1.13
Leptomeningeal spinal metastases from glioblastoma multiforme: treatment and management of an uncommon manifestation of disease. J Neurosurg Spine (2012) 1.11
A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg (2010) 1.11
Modular functional organization of cat anterior auditory field. J Neurophysiol (2004) 1.10
Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad. BMC Complement Altern Med (2005) 1.09
A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg (2010) 1.07
Monitoring of regulatory T cell frequencies and expression of CTLA-4 on T cells, before and after DC vaccination, can predict survival in GBM patients. PLoS One (2012) 1.07
Integration of preoperative anatomic and metabolic physiologic imaging of newly diagnosed glioma. J Neurooncol (2009) 1.06
Cranial chondrosarcoma and recurrence. Skull Base (2010) 1.06
Craniopharyngioma: a comparison of tumor control with various treatment strategies. Neurosurg Focus (2010) 1.05
Descending projections to the inferior colliculus from the posterior thalamus and the auditory cortex in rat, cat, and monkey. Hear Res (2002) 1.04
Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy. Neurosurg Clin N Am (2010) 1.04
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol (2014) 1.04